Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | FIST | CDK Inhibitors Patent Landscape 2009

CDK Inhibitors Patent Landscape 2009

IP Overview presents a patent landscape analysis of the CDK Inhibitor field.

Alterations in CDK activity have been associated in the development of viral infections, neurodegenerative dis orders such as Alzheimer’s disease and proliferative diseases such as renal diseases and cancers. These observations led the CDK family to become a central target for the development of new therapies.

During the last two decades, evolution of patent filings of CDK inhibit ors shows two major phases. A strong increase until 2002 is associated with the capacity of CDK inhibitors to target a large number of diseases. Results of advanced clinical stages confirm the potential of these compounds but emphasize new challenges in order to reach marketable products. A significant decrease follows until 2005 when a new generation of CDK inhibitors takes the lead in R&D interest.

This IP Overview provides you with a comprehensive panorama of the intellectual property landscape of this new and promising sector and helps you:

- Position your company’s R&D and IP Portfolio,

- Identify key inventors and key players involved in specific thematic,

- Understand the collaboration networks and theirs dynamics,

- Uncover trends and emerging segments

2009 PDF
More information
Sample Report
Price: $1,645.00 / €1,099.52

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions